RM
Rajkumar Malayandi
National Institute of Pharmaceutical Education and Research, Abbott (India), USV Private Limited
Employment
-
National Institute of Pharmaceutical Education and Research Head of the Department2023 - Present
-
Abbott (India) Head2021 - 2023
-
USV Private Limited Deputy GM2019 - 2021
-
Sun Pharma (India) Vadodara Head- Biopharmaceutics2014 - 2019
-
Dr. Reddy's Sr. Scientist2012 - 2014
-
FDC Limited Head2008 - 2012
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (45)
- Process Optimisation, Pharmaceutical Characterisation, and in vitro Activity of Mesalamine Nanocrystals in PMA-differentiated THP-1 cell Lines in the Late Inflammatory and Profibrotic Phase Save
- Forced degradation studies of palbociclib using validated RP-HPLC method and elucidation of degradation pathways and qualifying impurities using LC-HRMS analysis: A preformulation protocol Save
- Development of oral paediatric furosemide liquid formulation using surfactant-rich micelles Save
- Reverse Engineering of Branded Mesalamine Prolonged Release Granules for Synthesis of QTPP and FMEA: A Systematic Approach for Oral Complex Generic Product Development Save
- In silico designing of palbociclib loaded PLGA long-acting intramuscular injection for palliative therapy of HR+/HER2− metastatic breast cancer Save
- Dissolution behaviour of mesalamine nanocrystals, micronised crystals, suspensions, and tablets: a method development perspective Save
- Influence of pH, Buffering Capacity, Ionic Strength, Bile Salts, and Model Drugs on Micellization Behaviour of Salcaprozate Sodium in Physiological Range pH Buffers Save
- An In silico model-based feasibility assessment of erlotinib long-acting injectable formulation for the management of metastatic non-small cell lung cancer Save
- Thermally Stressed Solid-State Stability of Semaglutide: Understanding the Influence of Temperature on Protein Content, Secondary Structure, Phase Transition, and Chemical Degradation Save
- Forced degradation study and impurity profiling of erlotinib hydrochloride using RP-HPLC and orbitrap LC-HRMS analysis and their in silico toxicity assessment Save